{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:37:29Z","timestamp":1781375849169,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"vor","delay-in-days":273,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2011\/12199-0"],"award-info":[{"award-number":["2011\/12199-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cyto.2016.08.030","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T19:45:34Z","timestamp":1472845534000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis"],"prefix":"10.1016","volume":"88","author":[{"given":"Fabiana A.","family":"Zambuzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla M.","family":"Cardoso-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena S.","family":"Espindola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana S.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo J.","family":"Galv\u00e3o-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f4nica S.","family":"Brauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus S.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence R.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdes R.","family":"Bollela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiani G.","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.08.030_b0005","unstructured":"WHO, Global Tuberculosis Report 2015, 2015."},{"key":"10.1016\/j.cyto.2016.08.030_b0010","doi-asserted-by":"crossref","unstructured":"H. McShane, W. Jacobs, P. Fine, S. Reed, D. McMurray, M. Behr, A. Willians, I. Orme, BCG: myths, realities, and the need for alternative vaccine strategies, 92 (2012) 283\u2013288.","DOI":"10.1016\/j.tube.2011.12.003"},{"key":"10.1016\/j.cyto.2016.08.030_b0015","doi-asserted-by":"crossref","unstructured":"B. Kagina, B. Abel, T. Scriba, E. Hughes, A. Keyser, A. Soares, H. Gamieldien, M. Sidibana, M. Hatherrill, S. Gelderbloem, et al., Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns, 182 (2010) 1073\u20131079.","DOI":"10.1164\/rccm.201003-0334OC"},{"issue":"5","key":"10.1016\/j.cyto.2016.08.030_b0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5588\/ijtld.15.0048","article-title":"Advances in the diagnosis of tuberculosis: current status and future prospects","volume":"19","author":"Dorman","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"2","key":"10.1016\/j.cyto.2016.08.030_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1574-695X.2008.00400.x","article-title":"Extensively drug-resistant tuberculosis: current challenges and threats","volume":"53","author":"Jain","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.cyto.2016.08.030_b0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1573398X113099990017","article-title":"Recent advances in tuberculosis: new drugs and treatment regimens","volume":"9","author":"Sloan","year":"2013","journal-title":"Curr. Respir. Med. Rev."},{"key":"10.1016\/j.cyto.2016.08.030_b0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-9-450","article-title":"The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review","volume":"9","author":"Rehm","year":"2009","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.cyto.2016.08.030_b0040","doi-asserted-by":"crossref","first-page":"e96433","DOI":"10.1371\/journal.pone.0096433","article-title":"Tobacco smoking, alcohol drinking, diabetes, low body mass index and the risk of self-reported symptoms of active tuberculosis: individual participant data (IPD) meta-analyses of 72,684 individuals in 14 high tuberculosis burden countries","volume":"9","author":"Patra","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12269","article-title":"The human immune response to tuberculosis and its treatment: a view from the blood","volume":"264","author":"Cliff","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2016.08.030_b0050","doi-asserted-by":"crossref","unstructured":"Biomarkers_Definitions_Working_Group, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Clin. Pharmacol. Ther. 69(3) (2001) 89\u201395.","DOI":"10.1067\/mcp.2001.113989"},{"key":"10.1016\/j.cyto.2016.08.030_b0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.2012.06802.x","article-title":"The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis","volume":"1283","author":"Weiner","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/rccm.201201-0037OC","article-title":"Combination biomarkers to diagnose sepsis in the critically ill patient","volume":"186","author":"Gibot","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7309","key":"10.1016\/j.cyto.2016.08.030_b0065","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cyto.2016.08.030_b0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-007-0157-6","article-title":"Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis","volume":"85","author":"Jacobsen","year":"2007","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2014.06.002","article-title":"Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy","volume":"62","author":"Chowdhury","year":"2014","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2016.08.030_b0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri2960","article-title":"Immunological biomarkers of tuberculosis","volume":"11","author":"Walzl","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2016.08.030_b0085","doi-asserted-by":"crossref","first-page":"e108854","DOI":"10.1371\/journal.pone.0108854","article-title":"Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study","volume":"9","author":"Frediani","year":"2014","journal-title":"PLoS ONE"},{"issue":"9540","key":"10.1016\/j.cyto.2016.08.030_b0090","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(06)69342-2","article-title":"Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum","volume":"368","author":"Agranoff","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2016.08.030_b0095","doi-asserted-by":"crossref","unstructured":"CDC, Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement, Am. J. Respir. Crit. Care Med. 161(4 Pt 2) (2000) S221\u201347.","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"issue":"2","key":"10.1016\/j.cyto.2016.08.030_b0100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10753-014-9978-y","article-title":"The relationship between inflammatory marker levels and pulmonary tuberculosis severity","volume":"38","author":"Abakay","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.cyto.2016.08.030_b0105","doi-asserted-by":"crossref","first-page":"910621","DOI":"10.1155\/2014\/910621","article-title":"U.C.T.B.G.-UFMG-CTBG, Biomarker analysis revealed distinct profiles of innate and adaptive immunity in infants with ocular lesions of congenital toxoplasmosis","volume":"2014","author":"Machado","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"11","key":"10.1016\/j.cyto.2016.08.030_b0110","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.cyto.2016.08.030_b0115","first-page":"35","volume":"6","author":"Taylor","year":"1990","journal-title":"Interpretation of the correlation coefficient: a basic review"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cyto.2010.04.005","article-title":"Cytokine interactions that determine the outcome of Mycobacterial infection of macrophages","volume":"51","author":"Reljic","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.08.030_b0125","doi-asserted-by":"crossref","first-page":"639107","DOI":"10.1155\/2015\/639107","article-title":"Complexity and controversies over the cytokine profiles of T helper cell subpopulations in tuberculosis","volume":"2015","author":"da Silva","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.freeradbiomed.2005.02.031","article-title":"Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes","volume":"39","author":"Timmermann","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1189\/jlb.1205756","article-title":"Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163","volume":"80","author":"Weaver","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"4975","key":"10.1016\/j.cyto.2016.08.030_b0140","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1126\/science.1698311","article-title":"CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein","volume":"249","author":"Wright","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.cyto.2016.08.030_b0145","first-page":"40","volume":"4","author":"Arlot","year":"2010","journal-title":"A survey of cross-validation procedures for model selection"},{"key":"10.1016\/j.cyto.2016.08.030_b0150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O\u2019Garra","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2016.08.030_b0155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CMR.15.2.294-309.2002","article-title":"Innate immunity to Mycobacterium tuberculosis","volume":"15","author":"van Crevel","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-3083.2001.00844.x","article-title":"Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts","volume":"53","author":"Olobo","year":"2001","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2016.08.030_b0165","first-page":"299","article-title":"Comparative and prospective study of different immune parameters in healthy subjects at risk for tuberculosis and in tuberculosis patients","volume":"9","author":"Portales-P\u00e9rez","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"6817","key":"10.1016\/j.cyto.2016.08.030_b0170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2011.626868","article-title":"Soluble CD163","volume":"72","author":"M\u00f8ller","year":"2012","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0180","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1189\/jlb.1003523","article-title":"Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163","volume":"76","author":"Sulahian","year":"2004","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.030_b0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V99.1.378","article-title":"Identification of the hemoglobin scavenger receptor\/CD163 as a natural soluble protein in plasma","volume":"99","author":"M\u00f8ller","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cyto.2016.08.030_b0190","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.161.8.4244","article-title":"Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay","volume":"161","author":"Yu","year":"1998","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2016.08.030_b0195","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/eji.1830240911","article-title":"The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes","volume":"24","author":"Durieux","year":"1994","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2016.08.030_b0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.1991.tb05722.x","article-title":"Serum CD14 levels in polytraumatized and severely burned patients","volume":"85","author":"Kr\u00fcger","year":"1991","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2016.08.030_b0205","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.5588\/ijtld.11.0827","article-title":"Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis","volume":"16","author":"Alavi-Naini","year":"2012","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"6","key":"10.1016\/j.cyto.2016.08.030_b0210","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1378\/chest.108.6.1614","article-title":"Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis","volume":"108","author":"Hoheisel","year":"1995","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.cyto.2016.08.030_b0215","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1469-0691.2005.01229.x","article-title":"Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients","volume":"11","author":"Knudsen","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"issue":"12","key":"10.1016\/j.cyto.2016.08.030_b0220","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/cr.2015.123","article-title":"Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16(+) monocyte population via the IL-10\/STAT3 axis","volume":"25","author":"Lastrucci","year":"2015","journal-title":"Cell Res."},{"issue":"7","key":"10.1016\/j.cyto.2016.08.030_b0225","doi-asserted-by":"crossref","first-page":"e69896","DOI":"10.1371\/journal.pone.0069896","article-title":"Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses","volume":"8","author":"Feruglio","year":"2013","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.cyto.2016.08.030_b0230","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1084\/jem.194.12.1847","article-title":"Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology","volume":"194","author":"Ehlers","year":"2001","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cyto.2016.08.030_b0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1590\/S1413-86702008000300013","article-title":"Correlation between serum tumor necrosis factor alpha levels and clinical severity of tuberculosis","volume":"12","author":"Andrade J\u00fanior","year":"2008","journal-title":"Braz. J. Infect. Dis."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616304847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616304847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:51:03Z","timestamp":1760907063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616304847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":47,"alternative-id":["S1043466616304847"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.08.030","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}